Price
$0.17
Decreased by -2.58%
Dollar Volume (20D)
77.54 K
ADR%
7.62
Earnings Report Date (estimate)
May 9, 24
Shares Float
23.42 M
Shares Outstanding
29.72 M
Shares Short
845.17 K
Market Cap.
5.19 M
Beta
0.2
Price / Earnings
N/A
20D Range
0.16 0.22
50D Range
0.16 0.28
200D Range
0.16 0.93
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Nov 8, 23 -0.45
Increased by +37.5%
-0.61
Increased by +26.23%
Aug 7, 23 -0.63
Increased by +54.35%
-0.64
Increased by +1.56%
May 11, 23 -0.57
Increased by +43%
-0.69
Increased by +17.39%
Mar 16, 23 0.41
Increased by +136.61%
-0.71
Increased by +157.75%
Nov 10, 22 -0.72
Increased by +23.4%
-0.81
Increased by +11.11%
Aug 11, 22 -1.38
Decreased by -35.29%
-0.8
Decreased by -72.5%
May 12, 22 -1
Increased by +3.85%
-0.92
Decreased by -8.7%
Mar 30, 22 -1.12
Decreased by -6.67%
-0.83
Decreased by -34.94%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 23 5.24 M
Increased by +43.74%
-13.24 M
Increased by +35.08%
Decreased by -252.71%
Increased by +54.83%
Jun 30, 23 5.29 M
Increased by +29.76%
-18.35 M
Decreased by -425.37%
Decreased by -346.87%
Decreased by -304.88%
Mar 31, 23 4.17 M
Increased by +13.28%
-16.63 M
Increased by +59.83%
Decreased by -398.8%
Increased by +64.54%
Dec 31, 22 4.96 M
Increased by +13.76%
15.11 M
Increased by +148.32%
Increased by +304.47%
Increased by +142.48%
Sep 30, 22 3.64 M
Decreased by -20.8%
-20.39 M
Increased by +28.49%
Decreased by -559.52%
Increased by +9.71%
Jun 30, 22 4.08 M
Decreased by -13.44%
-3.49 M
Increased by +87.84%
Decreased by -85.67%
Increased by +85.96%
Mar 31, 22 3.68 M
Increased by +2.51%
-41.4 M
Decreased by -41.89%
Decreased by -1.12 K%
Decreased by -38.42%
Dec 31, 21 4.36 M
Increased by +69.46%
-31.26 M
Decreased by -6.33%
Decreased by -716.74%
Increased by +37.25%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was incorporated in 2011 and is headquartered in Carlsbad, California.